Navigation Links
Healthcare Providers Rate Elekta's MOSAIQ Oncology Information System as No. 1 in 2010 KLAS Report
Date:10/6/2010

ATLANTA, Oct. 6 /PRNewswire/ – A recent KLAS survey of 137 healthcare providers show high satisfaction for Elekta's combined oncology information system (OIS), MOSAIQ® Radiation Oncology / MOSAIQ® Medical Oncology. The integrated MOSAIQ solution—the market's leading open-system, vendor-independent OIS—earned the top ranking. In addition, 88 percent of respondents indicated they would buy MOSAIQ again.

In the KLAS 2010 report, titled The Oncology IT Balancing Act: Integration vs. Functionality, Elekta vaulted over its competitors to claim the No. 1 rank. Customer comments and survey analysis indicated Elekta's focus on service and support, its delivery of solid, all-around functionality—particularly the scheduling module which is a part of MOSAIQ's comprehensive practice management solution—and Elekta's ability to provide "the most consistent client experience, regardless of facility size or geographic region," were key factors in its latest ranking.

Elekta's OIS offerings received top scores in:

  • Product worked as promoted
  • Implementation on time
  • Quality of training
  • Overall product quality
  • Supports integration goals
  • Keeps promises

Elekta also tied for the top scores in:

  • Delivery of new technology
  • Quality of phone / web support
  • Proactive service

"Streamlining information flow in cancer management environments is a top priority among healthcare providers as they work to fulfill federal government guidelines for electronic medical records (EMR) systems as specified in the HITECH Act," says Todd Powell, Executive Vice President Elekta Software.

"We have worked to make our MOSAIQ products not only the most comprehensive, interoperable and robust solutions available, but also equipped them to perform functions that all modern EMRs should have to increase efficiency in patient care," he says. "This report provides yet another example in support of our efforts and shows that we're addressing the issues that our customers believe are the most important."

KLAS independently monitors vendor performance through the active participation of thousands of healthcare organizations and uses a stringent methodology to ensure all data and ratings are accurate, honest and impartial.

Read more about the world's leading multi-vendor, multi-specialty data management system at www.elekta.com/mosaiq.  

About MOSAIQ

MOSAIQ is a dedicated oncology information system that streamlines the entire medical oncology or radiation oncology workflow from diagnosis and staging, through planning, treatment, follow-up and long-term survivorship. At the heart of MOSAIQ is the image-enabled electronic medical record by which healthcare professionals communicate information about their patients through the entire spectrum of cancer care.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible. Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.

About KLAS

KLAS is an independent research firm specializing in monitoring and reporting the performance of healthcare vendors. KLAS' mission is to improve delivery, by independently measuring vendor performance for the benefit of our healthcare provider partners, consultants, investors and vendors. Working together with executives from more than 4,500 hospitals and over 2,500 clinics, KLAS delivers timely reports, trends and statistics, which provide a solid overview of vendor performance in the industry. KLAS measures the performance of software, professional services and medical equipment vendors. For more information, go to www.KLASresearch.com, email marketing@KLASresearch.com or call 1-800-920-4109 to speak with a KLAS representative. Copyright© 2010 KLAS Enterprises, LLC. All rights reserved.


'/>"/>
SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. ViroPharma to Present at Three Upcoming Healthcare Conferences
4. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
5. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
6. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
7. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
8. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
9. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
10. Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5
11. Immtech to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017  Novartis announced today ... has accepted the company,s Biologics License Application (BLA) ... an investigational chimeric antigen receptor T cell (CAR-T) ... young adult patients with B-cell acute lymphoblastic leukemia ... Novartis for a CAR-T. The priority review designation ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "South ... & Forecast" report to their offering. ... The South Korean Proton Therapy Market is expected to ... Untapped Proton Therapy Market for South Korea was ... Proton Therapy plays an important role in delivering comprehensive cancer care to ...
(Date:3/29/2017)... 29, 2017  Zynex (OTCQB: ZYXI), an innovative medical technology ... medical devices for pain management, stroke rehabilitation, cardiac monitoring ... the Company,s 2016 full-year investor webcast on Monday, April 3, ... The Company expects to file its 2016 full year ... ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... 2017 , ... Patients interested in receiving quick and effective ... Cameron, with or without a referral. The FASTBRACES system is valued for its ... patient’s case, treatment with the FASTBRACES system could be completed in 120 days ...
(Date:3/29/2017)... ANN ARBOR, Mich. (PRWEB) , ... ... ... Global Retailer and Manufacturer Alliance (GRMA) is growing as it continues developing ... the dietary supplement industry. The organization, which plans to publish the first ...
(Date:3/29/2017)... ... March 29, 2017 , ... Altima Technologies, Inc., ... network and data center assets and audio-video devices has recently updated its Visio ... shapes for free and download shapes and stencils from http://www.VisioStencils.com. , ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... oral braces. "The rubber bands used in conjunction with my braces always rubbed ... to design a way to prevent this problem." The O.B.S. was the result ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly ... assembly protocols involve many repetitive steps and often scientists require many different versions ... high-throughput needed, and results in a lower error rate and cost saving for ...
Breaking Medicine News(10 mins):